PIA Puerto Rico

From educational programs to social responsibility projects, PIA drives initiatives that create positive community impact while strengthening the sustainability of the industry.

Collaboration with patient organizations and strategic workshops allowed us to define concrete actions to influence patient-centered policies. The goal: timely access, effective education, and decisions grounded in real patient needs.

PIA enhances operational excellence through regulatory conferences, best practice exchanges, and cross-industry collaboration, ensuring compliance, safety, and quality across all processes.

Still haven't marked your calendar? Here's your reminder!

The 24th PIA Regulatory Conference — Advancing Compliance and Operational Excellence is taking place on Friday, August 14, 2026, at the Caribe Hilton.

Registration details are on the way. Don't miss it!

The Pharmaceutical Industry Association of Puerto Rico (PIA) strengthens its leadership with new appointments to its Board of Directors.

As part of the organization’s new chapter under the presidency of David Thompson, several leadership changes have been officially confirmed, reinforcing continuity, expertise, and strategic vision within the Board.

These appointments reaffirm PIA’s commitment to advancing the pharmaceutical industry in Puerto Rico by promoting innovation, expanding access to treatments, and supporting the island’s economic growth.

Meet the new Board of Directors.

Save the Date!

The 24th PIA Regulatory Conference will take place on August 14, 2026, at the Caribe Hilton. Where industry meets innovation.

More details coming soon!

We promote disease management models and the scientific exchange of evidence-based practices to improve care standards and optimize health outcomes for patients across Puerto Rico.

Through university partnerships, workshops, mentorship programs, and the creation of PILA, PIA develops the next generation of pharmaceutical leaders and professionals, strengthening local talent and the industry.

PIA promotes a shift in healthcare focus: from cost to value. Biopharmaceutical innovation not only improves patient outcomes but also optimizes resources and strengthens care standards in Puerto Rico.

In 2025, PIA strengthened the patient voice within the biopharmaceutical industry, fostering effective collaboration and adoption of best practices. In 2026, we continue to focus on patient education for prevention and healthy lifestyles, while expanding access to care for all.